APO Research
Talk to an analyst

APO RESEARCH · REPORT

Clinical Grade Gene Test Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Clinical Grade Gene Test Service Market Analysis and Forecast 2026-2032

2 January 2026194 pages

Choose your research edition.

Industry ResearchClinical Grade Gene Test Service Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Clinical Grade Gene Test Service Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Clinical Grade Gene Test Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Clinical Grade Gene Test Service Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Clinical Grade Gene Test Service Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Clinical Grade Gene Test Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Clinical Grade Gene Test Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Clinical Grade Gene Test Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Clinical Grade Gene Test Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Clinical Grade Gene Test Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Clinical Grade Gene Test Service include Illumina, BGI Genomics Co.,Ltd., Agilent Technologies, Macrogen, Pacific Biosciences, 10x Genomics, QIAGEN, GEEWIZ and MACROGEN, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Clinical Grade Gene Test Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Clinical Grade Gene Test Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Clinical Grade Gene Test Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Clinical Grade Gene Test Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Clinical Grade Gene Test Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Clinical Grade Gene Test Service revenue, projected growth trends, production technology, application and end-user industry.

Clinical Grade Gene Test Service Segment by Company

Illumina

BGI Genomics Co.,Ltd.

Agilent Technologies

Macrogen

Pacific Biosciences

10x Genomics

QIAGEN

GEEWIZ

MACROGEN

WeGene

23andMe

Mega Genomics

Berry Genomics

CapitalBio Corp.

Annaroad Gene Technology(Beijing)Co., Ltd.

Clinical Grade Gene Test Service Segment by Type

Prenatal Screening

Detection of Microorganism

Screening for Genetic Diseases

Tumor Diagnosis and Treatment

Clinical Grade Gene Test Service Segment by Application

Gene Chip Technology

PCR

High-throughput Sequencing

Clinical Grade Gene Test Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clinical Grade Gene Test Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Clinical Grade Gene Test Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Clinical Grade Gene Test Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Clinical Grade Gene Test Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Clinical Grade Gene Test Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Clinical Grade Gene Test Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Clinical Grade Gene Test Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Prenatal Screening Major Player Table 3. Detection of Microorganism Major Player Table 4. Screening for Genetic Diseases Major Player Table 5. Tumor Diagnosis and Treatment Major Player Table 6. Global Clinical Grade Gene Test Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Gene Chip Technology Major Player Table 8. PCR Major Player Table 9. High-throughput Sequencing Major Player Table 10. Clinical Grade Gene Test Service Industry Trends Table 11. Clinical Grade Gene Test Service Industry Drivers Table 12. Clinical Grade Gene Test Service Industry Opportunities and Challenges Table 13. Clinical Grade Gene Test Service Industry Restraints Table 14. Global Clinical Grade Gene Test Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Clinical Grade Gene Test Service Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Clinical Grade Gene Test Service Market Share by Region (2021-2026) Table 17. Global Clinical Grade Gene Test Service Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Clinical Grade Gene Test Service Market Share by Region (2027-2032) Table 19. Global Clinical Grade Gene Test Service Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Clinical Grade Gene Test Service Revenue Market Share by Players (2021-2026) Table 21. Global Clinical Grade Gene Test Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Clinical Grade Gene Test Service Key Players Headquarters & Area Served Table 23. Global Clinical Grade Gene Test Service Players, Product Type & Application Table 24. Global Clinical Grade Gene Test Service Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Clinical Grade Gene Test Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Clinical Grade Gene Test Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Clinical Grade Gene Test Service Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Clinical Grade Gene Test Service Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Clinical Grade Gene Test Service Revenue Market Share by Type (2021-2026) Table 31. Global Clinical Grade Gene Test Service Revenue Market Share by Type (2027-2032) Table 32. Global Clinical Grade Gene Test Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Clinical Grade Gene Test Service Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Clinical Grade Gene Test Service Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Clinical Grade Gene Test Service Revenue Market Share by Application (2021-2026) Table 36. Global Clinical Grade Gene Test Service Revenue Market Share by Application (2027-2032) Table 37. Illumina Company Information Table 38. Illumina Business Overview Table 39. Illumina Clinical Grade Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Illumina Clinical Grade Gene Test Service Product Portfolio Table 41. Illumina Recent Development Table 42. BGI Genomics Co.,Ltd. Company Information Table 43. BGI Genomics Co.,Ltd. Business Overview Table 44. BGI Genomics Co.,Ltd. Clinical Grade Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. BGI Genomics Co.,Ltd. Clinical Grade Gene Test Service Product Portfolio Table 46. BGI Genomics Co.,Ltd. Recent Development Table 47. Agilent Technologies Company Information Table 48. Agilent Technologies Business Overview Table 49. Agilent Technologies Clinical Grade Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Agilent Technologies Clinical Grade Gene Test Service Product Portfolio Table 51. Agilent Technologies Recent Development Table 52. Macrogen Company Information Table 53. Macrogen Business Overview Table 54. Macrogen Clinical Grade Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Macrogen Clinical Grade Gene Test Service Product Portfolio Table 56. Macrogen Recent Development Table 57. Pacific Biosciences Company Information Table 58. Pacific Biosciences Business Overview Table 59. Pacific Biosciences Clinical Grade Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Pacific Biosciences Clinical Grade Gene Test Service Product Portfolio Table 61. Pacific Biosciences Recent Development Table 62. 10x Genomics Company Information Table 63. 10x Genomics Business Overview Table 64. 10x Genomics Clinical Grade Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. 10x Genomics Clinical Grade Gene Test Service Product Portfolio Table 66. 10x Genomics Recent Development Table 67. QIAGEN Company Information Table 68. QIAGEN Business Overview Table 69. QIAGEN Clinical Grade Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. QIAGEN Clinical Grade Gene Test Service Product Portfolio Table 71. QIAGEN Recent Development Table 72. GEEWIZ Company Information Table 73. GEEWIZ Business Overview Table 74. GEEWIZ Clinical Grade Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. GEEWIZ Clinical Grade Gene Test Service Product Portfolio Table 76. GEEWIZ Recent Development Table 77. MACROGEN Company Information Table 78. MACROGEN Business Overview Table 79. MACROGEN Clinical Grade Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. MACROGEN Clinical Grade Gene Test Service Product Portfolio Table 81. MACROGEN Recent Development Table 82. WeGene Company Information Table 83. WeGene Business Overview Table 84. WeGene Clinical Grade Gene Test Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. WeGene Clinical Grade Gene Test Service Product Portfolio Table 86. WeGene Recent Development Table 87. 23andMe Company Information Table 88. 23andMe Business Overview Table 89. 23andMe Clinical Grade Gene Test Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. 23andMe Clinical Grade Gene Test Service Product Portfolio Table 91. 23andMe Recent Development Table 92. Mega Genomics Company Information Table 93. Mega Genomics Business Overview Table 94. Mega Genomics Clinical Grade Gene Test Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Mega Genomics Clinical Grade Gene Test Service Product Portfolio Table 96. Mega Genomics Recent Development Table 97. Berry Genomics Company Information Table 98. Berry Genomics Business Overview Table 99. Berry Genomics Clinical Grade Gene Test Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Berry Genomics Clinical Grade Gene Test Service Product Portfolio Table 101. Berry Genomics Recent Development Table 102. CapitalBio Corp. Company Information Table 103. CapitalBio Corp. Business Overview Table 104. CapitalBio Corp. Clinical Grade Gene Test Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. CapitalBio Corp. Clinical Grade Gene Test Service Product Portfolio Table 106. CapitalBio Corp. Recent Development Table 107. Annaroad Gene Technology(Beijing)Co., Ltd. Company Information Table 108. Annaroad Gene Technology(Beijing)Co., Ltd. Business Overview Table 109. Annaroad Gene Technology(Beijing)Co., Ltd. Clinical Grade Gene Test Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Annaroad Gene Technology(Beijing)Co., Ltd. Clinical Grade Gene Test Service Product Portfolio Table 111. Annaroad Gene Technology(Beijing)Co., Ltd. Recent Development Table 112. North America Clinical Grade Gene Test Service Revenue by Type (2021-2026) & (US$ Million) Table 113. North America Clinical Grade Gene Test Service Revenue by Type (2027-2032) & (US$ Million) Table 114. North America Clinical Grade Gene Test Service Revenue by Application (2021-2026) & (US$ Million) Table 115. North America Clinical Grade Gene Test Service Revenue by Application (2027-2032) & (US$ Million) Table 116. North America Clinical Grade Gene Test Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. North America Clinical Grade Gene Test Service Revenue by Country (2021-2026) & (US$ Million) Table 118. North America Clinical Grade Gene Test Service Revenue by Country (US$ Million) & (2027-2032) Table 119. Europe Clinical Grade Gene Test Service Revenue by Type (2021-2026) & (US$ Million) Table 120. Europe Clinical Grade Gene Test Service Revenue by Type (2027-2032) & (US$ Million) Table 121. Europe Clinical Grade Gene Test Service Revenue by Application (2021-2026) & (US$ Million) Table 122. Europe Clinical Grade Gene Test Service Revenue by Application (2027-2032) & (US$ Million) Table 123. Europe Clinical Grade Gene Test Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Europe Clinical Grade Gene Test Service Revenue by Country (2021-2026) & (US$ Million) Table 125. Europe Clinical Grade Gene Test Service Revenue by Country (US$ Million) & (2027-2032) Table 126. China Clinical Grade Gene Test Service Revenue by Type (2021-2026) & (US$ Million) Table 127. China Clinical Grade Gene Test Service Revenue by Type (2027-2032) & (US$ Million) Table 128. China Clinical Grade Gene Test Service Revenue by Application (2021-2026) & (US$ Million) Table 129. China Clinical Grade Gene Test Service Revenue by Application (2027-2032) & (US$ Million) Table 130. Asia Clinical Grade Gene Test Service Revenue by Type (2021-2026) & (US$ Million) Table 131. Asia Clinical Grade Gene Test Service Revenue by Type (2027-2032) & (US$ Million) Table 132. Asia Clinical Grade Gene Test Service Revenue by Application (2021-2026) & (US$ Million) Table 133. Asia Clinical Grade Gene Test Service Revenue by Application (2027-2032) & (US$ Million) Table 134. Asia Clinical Grade Gene Test Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 135. Asia Clinical Grade Gene Test Service Revenue by Region (US$ Million) & (2021-2026) Table 136. Asia Clinical Grade Gene Test Service Revenue by Region (US$ Million) & (2027-2032) Table 137. SAMEA Clinical Grade Gene Test Service Revenue by Type (2021-2026) & (US$ Million) Table 138. SAMEA Clinical Grade Gene Test Service Revenue by Type (2027-2032) & (US$ Million) Table 139. SAMEA Clinical Grade Gene Test Service Revenue by Application (2021-2026) & (US$ Million) Table 140. SAMEA Clinical Grade Gene Test Service Revenue by Application (2027-2032) & (US$ Million) Table 141. SAMEA Clinical Grade Gene Test Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. SAMEA Clinical Grade Gene Test Service Revenue by Country (2021-2026) & (US$ Million) Table 143. SAMEA Clinical Grade Gene Test Service Revenue by Country (US$ Million) & (2027-2032) Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Clinical Grade Gene Test Service Image Figure 2. Global Clinical Grade Gene Test Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Clinical Grade Gene Test Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Prenatal Screening Image Figure 5. Detection of Microorganism Image Figure 6. Screening for Genetic Diseases Image Figure 7. Tumor Diagnosis and Treatment Image Figure 8. Global Clinical Grade Gene Test Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Clinical Grade Gene Test Service Market Size Share 2021 VS 2025 VS 2032 Figure 10. Gene Chip Technology Image Figure 11. PCR Image Figure 12. High-throughput Sequencing Image Figure 13. Global Clinical Grade Gene Test Service Market Size (US$ Million) & (2021-2032) Figure 14. Global Clinical Grade Gene Test Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Clinical Grade Gene Test Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Clinical Grade Gene Test Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Clinical Grade Gene Test Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Clinical Grade Gene Test Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Clinical Grade Gene Test Service Revenue Market Share by Type (2021-2032) Figure 21. Global Clinical Grade Gene Test Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Clinical Grade Gene Test Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Clinical Grade Gene Test Service Revenue Market Share by Application (2021-2032) Figure 24. North America Clinical Grade Gene Test Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Clinical Grade Gene Test Service Revenue Share by Type (2021-2032) Figure 26. North America Clinical Grade Gene Test Service Revenue Share by Application (2021-2032) Figure 27. North America Clinical Grade Gene Test Service Revenue Share by Country (2021-2032) Figure 28. United States Clinical Grade Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Clinical Grade Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Clinical Grade Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Clinical Grade Gene Test Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Clinical Grade Gene Test Service Revenue Share by Type (2021-2032) Figure 33. Europe Clinical Grade Gene Test Service Revenue Share by Application (2021-2032) Figure 34. Europe Clinical Grade Gene Test Service Revenue Share by Country (2021-2032) Figure 35. Germany Clinical Grade Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Clinical Grade Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Clinical Grade Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Clinical Grade Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Clinical Grade Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Clinical Grade Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Clinical Grade Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Clinical Grade Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Clinical Grade Gene Test Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Clinical Grade Gene Test Service Revenue Share by Type (2021-2032) Figure 45. China Clinical Grade Gene Test Service Revenue Share by Application (2021-2032) Figure 46. Asia Clinical Grade Gene Test Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Clinical Grade Gene Test Service Revenue Share by Type (2021-2032) Figure 48. Asia Clinical Grade Gene Test Service Revenue Share by Application (2021-2032) Figure 49. Asia Clinical Grade Gene Test Service Revenue Share by Region (2021-2032) Figure 50. Japan Clinical Grade Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Clinical Grade Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Clinical Grade Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Clinical Grade Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Clinical Grade Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Clinical Grade Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Clinical Grade Gene Test Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Clinical Grade Gene Test Service Revenue Share by Type (2021-2032) Figure 58. SAMEA Clinical Grade Gene Test Service Revenue Share by Application (2021-2032) Figure 59. SAMEA Clinical Grade Gene Test Service Revenue Share by Country (2021-2032) Figure 60. Brazil Clinical Grade Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Clinical Grade Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Clinical Grade Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Clinical Grade Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Clinical Grade Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Clinical Grade Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Clinical Grade Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Clinical Grade Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Clinical Grade Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Clinical Grade Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Clinical Grade Gene Test Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Prenatal Screening
  • Detection of Microorganism
  • Screening for Genetic Diseases
  • Tumor Diagnosis and Treatment
Applications
  • Gene Chip Technology
  • PCR
  • High-throughput Sequencing
Companies covered
  • Illumina
  • BGI Genomics Co.,Ltd.
  • Agilent Technologies
  • Macrogen
  • Pacific Biosciences
  • 10x Genomics
  • QIAGEN
  • GEEWIZ
  • MACROGEN
  • WeGene
  • 23andMe
  • Mega Genomics
  • Berry Genomics
  • CapitalBio Corp.
  • Annaroad Gene Technology(Beijing)Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Clinical Grade Gene Test Service Market by Type
  3. 1.2.1 Global Clinical Grade Gene Test Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Prenatal Screening
  5. 1.2.3 Detection of Microorganism
  6. 1.2.4 Screening for Genetic Diseases
  7. 1.2.5 Tumor Diagnosis and Treatment
  8. 1.3 Clinical Grade Gene Test Service Market by Application
  9. 1.3.1 Global Clinical Grade Gene Test Service Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Gene Chip Technology
  11. 1.3.3 PCR
  12. 1.3.4 High-throughput Sequencing
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Clinical Grade Gene Test Service Market Dynamics
  1. 2.1 Clinical Grade Gene Test Service Industry Trends
  2. 2.2 Clinical Grade Gene Test Service Industry Drivers
  3. 2.3 Clinical Grade Gene Test Service Industry Opportunities and Challenges
  4. 2.4 Clinical Grade Gene Test Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Clinical Grade Gene Test Service Market Perspective (2021-2032)
  2. 3.2 Global Clinical Grade Gene Test Service Growth Trends by Region
  3. 3.2.1 Global Clinical Grade Gene Test Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Clinical Grade Gene Test Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Clinical Grade Gene Test Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Clinical Grade Gene Test Service Revenue by Players
  2. 4.1.1 Global Clinical Grade Gene Test Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Clinical Grade Gene Test Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Clinical Grade Gene Test Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Clinical Grade Gene Test Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Clinical Grade Gene Test Service Key Players Headquarters & Area Served
  7. 4.4 Global Clinical Grade Gene Test Service Players, Product Type & Application
  8. 4.5 Global Clinical Grade Gene Test Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Clinical Grade Gene Test Service Market CR5 and HHI
  11. 4.6.3 2025 Clinical Grade Gene Test Service Tier 1, Tier 2, and Tier 3
5 Clinical Grade Gene Test Service Market Size by Type
  1. 5.1 Global Clinical Grade Gene Test Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Clinical Grade Gene Test Service Revenue by Type (2021-2032)
  3. 5.3 Global Clinical Grade Gene Test Service Revenue Market Share by Type (2021-2032)
6 Clinical Grade Gene Test Service Market Size by Application
  1. 6.1 Global Clinical Grade Gene Test Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Clinical Grade Gene Test Service Revenue by Application (2021-2032)
  3. 6.3 Global Clinical Grade Gene Test Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Illumina
  2. 7.1.1 Illumina Company Information
  3. 7.1.2 Illumina Business Overview
  4. 7.1.3 Illumina Clinical Grade Gene Test Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Illumina Clinical Grade Gene Test Service Product Portfolio
  6. 7.1.5 Illumina Recent Developments
  7. 7.2 BGI Genomics Co.,Ltd.
  8. 7.2.1 BGI Genomics Co.,Ltd. Company Information
  9. 7.2.2 BGI Genomics Co.,Ltd. Business Overview
  10. 7.2.3 BGI Genomics Co.,Ltd. Clinical Grade Gene Test Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 BGI Genomics Co.,Ltd. Clinical Grade Gene Test Service Product Portfolio
  12. 7.2.5 BGI Genomics Co.,Ltd. Recent Developments
  13. 7.3 Agilent Technologies
  14. 7.3.1 Agilent Technologies Company Information
  15. 7.3.2 Agilent Technologies Business Overview
  16. 7.3.3 Agilent Technologies Clinical Grade Gene Test Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Agilent Technologies Clinical Grade Gene Test Service Product Portfolio
  18. 7.3.5 Agilent Technologies Recent Developments
  19. 7.4 Macrogen
  20. 7.4.1 Macrogen Company Information
  21. 7.4.2 Macrogen Business Overview
  22. 7.4.3 Macrogen Clinical Grade Gene Test Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Macrogen Clinical Grade Gene Test Service Product Portfolio
  24. 7.4.5 Macrogen Recent Developments
  25. 7.5 Pacific Biosciences
  26. 7.5.1 Pacific Biosciences Company Information
  27. 7.5.2 Pacific Biosciences Business Overview
  28. 7.5.3 Pacific Biosciences Clinical Grade Gene Test Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Pacific Biosciences Clinical Grade Gene Test Service Product Portfolio
  30. 7.5.5 Pacific Biosciences Recent Developments
  31. 7.6 10x Genomics
  32. 7.6.1 10x Genomics Company Information
  33. 7.6.2 10x Genomics Business Overview
  34. 7.6.3 10x Genomics Clinical Grade Gene Test Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 10x Genomics Clinical Grade Gene Test Service Product Portfolio
  36. 7.6.5 10x Genomics Recent Developments
  37. 7.7 QIAGEN
  38. 7.7.1 QIAGEN Company Information
  39. 7.7.2 QIAGEN Business Overview
  40. 7.7.3 QIAGEN Clinical Grade Gene Test Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 QIAGEN Clinical Grade Gene Test Service Product Portfolio
  42. 7.7.5 QIAGEN Recent Developments
  43. 7.8 GEEWIZ
  44. 7.8.1 GEEWIZ Company Information
  45. 7.8.2 GEEWIZ Business Overview
  46. 7.8.3 GEEWIZ Clinical Grade Gene Test Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 GEEWIZ Clinical Grade Gene Test Service Product Portfolio
  48. 7.8.5 GEEWIZ Recent Developments
  49. 7.9 MACROGEN
  50. 7.9.1 MACROGEN Company Information
  51. 7.9.2 MACROGEN Business Overview
  52. 7.9.3 MACROGEN Clinical Grade Gene Test Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 MACROGEN Clinical Grade Gene Test Service Product Portfolio
  54. 7.9.5 MACROGEN Recent Developments
  55. 7.10 WeGene
  56. 7.10.1 WeGene Company Information
  57. 7.10.2 WeGene Business Overview
  58. 7.10.3 WeGene Clinical Grade Gene Test Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 WeGene Clinical Grade Gene Test Service Product Portfolio
  60. 7.10.5 WeGene Recent Developments
  61. 7.11 23andMe
  62. 7.11.1 23andMe Company Information
  63. 7.11.2 23andMe Business Overview
  64. 7.11.3 23andMe Clinical Grade Gene Test Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 23andMe Clinical Grade Gene Test Service Product Portfolio
  66. 7.11.5 23andMe Recent Developments
  67. 7.12 Mega Genomics
  68. 7.12.1 Mega Genomics Company Information
  69. 7.12.2 Mega Genomics Business Overview
  70. 7.12.3 Mega Genomics Clinical Grade Gene Test Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Mega Genomics Clinical Grade Gene Test Service Product Portfolio
  72. 7.12.5 Mega Genomics Recent Developments
  73. 7.13 Berry Genomics
  74. 7.13.1 Berry Genomics Company Information
  75. 7.13.2 Berry Genomics Business Overview
  76. 7.13.3 Berry Genomics Clinical Grade Gene Test Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Berry Genomics Clinical Grade Gene Test Service Product Portfolio
  78. 7.13.5 Berry Genomics Recent Developments
  79. 7.14 CapitalBio Corp.
  80. 7.14.1 CapitalBio Corp. Company Information
  81. 7.14.2 CapitalBio Corp. Business Overview
  82. 7.14.3 CapitalBio Corp. Clinical Grade Gene Test Service Revenue and Gross Margin (2021-2026)
  83. 7.14.4 CapitalBio Corp. Clinical Grade Gene Test Service Product Portfolio
  84. 7.14.5 CapitalBio Corp. Recent Developments
  85. 7.15 Annaroad Gene Technology(Beijing)Co., Ltd.
  86. 7.15.1 Annaroad Gene Technology(Beijing)Co., Ltd. Company Information
  87. 7.15.2 Annaroad Gene Technology(Beijing)Co., Ltd. Business Overview
  88. 7.15.3 Annaroad Gene Technology(Beijing)Co., Ltd. Clinical Grade Gene Test Service Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Annaroad Gene Technology(Beijing)Co., Ltd. Clinical Grade Gene Test Service Product Portfolio
  90. 7.15.5 Annaroad Gene Technology(Beijing)Co., Ltd. Recent Developments
8 North America
  1. 8.1 North America Clinical Grade Gene Test Service Revenue (2021-2032)
  2. 8.2 North America Clinical Grade Gene Test Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Clinical Grade Gene Test Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Clinical Grade Gene Test Service Revenue by Type (2027-2032)
  5. 8.3 North America Clinical Grade Gene Test Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Clinical Grade Gene Test Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Clinical Grade Gene Test Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Clinical Grade Gene Test Service Revenue by Application (2027-2032)
  9. 8.5 North America Clinical Grade Gene Test Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Clinical Grade Gene Test Service Revenue by Country
  11. 8.6.1 North America Clinical Grade Gene Test Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Clinical Grade Gene Test Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Clinical Grade Gene Test Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Clinical Grade Gene Test Service Revenue (2021-2032)
  2. 9.2 Europe Clinical Grade Gene Test Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Clinical Grade Gene Test Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Clinical Grade Gene Test Service Revenue by Type (2027-2032)
  5. 9.3 Europe Clinical Grade Gene Test Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Clinical Grade Gene Test Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Clinical Grade Gene Test Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Clinical Grade Gene Test Service Revenue by Application (2027-2032)
  9. 9.5 Europe Clinical Grade Gene Test Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Clinical Grade Gene Test Service Revenue by Country
  11. 9.6.1 Europe Clinical Grade Gene Test Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Clinical Grade Gene Test Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Clinical Grade Gene Test Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Clinical Grade Gene Test Service Revenue (2021-2032)
  2. 10.2 China Clinical Grade Gene Test Service Revenue by Type (2021-2032)
  3. 10.2.1 China Clinical Grade Gene Test Service Revenue by Type (2021-2026)
  4. 10.2.2 China Clinical Grade Gene Test Service Revenue by Type (2027-2032)
  5. 10.3 China Clinical Grade Gene Test Service Revenue Share by Type (2021-2032)
  6. 10.4 China Clinical Grade Gene Test Service Revenue by Application (2021-2032)
  7. 10.4.1 China Clinical Grade Gene Test Service Revenue by Application (2021-2026)
  8. 10.4.2 China Clinical Grade Gene Test Service Revenue by Application (2027-2032)
  9. 10.5 China Clinical Grade Gene Test Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Clinical Grade Gene Test Service Revenue (2021-2032)
  2. 11.2 Asia Clinical Grade Gene Test Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Clinical Grade Gene Test Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Clinical Grade Gene Test Service Revenue by Type (2027-2032)
  5. 11.3 Asia Clinical Grade Gene Test Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Clinical Grade Gene Test Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Clinical Grade Gene Test Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Clinical Grade Gene Test Service Revenue by Application (2027-2032)
  9. 11.5 Asia Clinical Grade Gene Test Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Clinical Grade Gene Test Service Revenue by Country
  11. 11.6.1 Asia Clinical Grade Gene Test Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Clinical Grade Gene Test Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Clinical Grade Gene Test Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Clinical Grade Gene Test Service Revenue (2021-2032)
  2. 12.2 SAMEA Clinical Grade Gene Test Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Clinical Grade Gene Test Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Clinical Grade Gene Test Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Clinical Grade Gene Test Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Clinical Grade Gene Test Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Clinical Grade Gene Test Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Clinical Grade Gene Test Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Clinical Grade Gene Test Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Clinical Grade Gene Test Service Revenue by Country
  11. 12.6.1 SAMEA Clinical Grade Gene Test Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Clinical Grade Gene Test Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Clinical Grade Gene Test Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst